Market Snapshot

BSE Sensex: 73088.33 0.83%
BSE 500: 32199.48 0.32%
BSE 200: 10088.94 0.39%
BSE 100: 23199.58 0.55%
BSE Mid-Cap: 40004.52 -0.39%
BSE Small-Cap: 45433.79 -0.04%
BANKEX: 53720.76 1.02%
BSE IT Sector: 34139.78 -0.56%
Nifty 50: 22147 0.69%
Nifty 500: 20385.2 0.30%
Nifty 200: 12325.85 0.35%
Nifty 100: 22859.8 0.53%
Nifty Midcap 100: 48696.95 -0.61%
Nifty Small 100: 16270.4 -0.10%
Nifty IT: 33368.3 -0.39%
Nifty PSU Bank: 6933.25 -0.29%

News:

IREDA Q4 PAT climbs 33% YoY to...
HDFC AMC Q4 PAT climbs 44% YoY...
Wipro Q4 PAT rises 5% QoQ to R...
Premier Explosives gains as bo...
Hindustan Zinc slides after Q4...

Welcure Drugs & Pharmaceuticals Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

19 Apr 2024 | 03:59 PM

4.40

-0.02 (-0.45%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

11.11%

Return (1Y)

Underperformed S&P BSE Sensex by 11.59%
More Volatile

3.2%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 2.57%
Not so consistent

5/12

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Welcure Drugs & Pharmaceuticals to conduct board meeting
28 days ago

Welcure Drugs & Pharmaceuticals to conduct board meeting

23 - Mar - 2024 12:00 AM | 28 days ago

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 March 2024.
Powered by Capital Market - Live News
Welcure Drugs & Pharmaceuticals reports standalone net loss of Rs 0.03 crore in the December 2023 quarter
65 days ago

Welcure Drugs & Pharmaceuticals reports standalone net loss of Rs 0.03 crore in the December 2023 quarter

15 - Feb - 2024 12:00 AM | 65 days ago

Net loss of Welcure Drugs & Pharmaceuticals reported to Rs 0.03 crore in the quarter ended December 2023. There were no net profit/loss reported during the previous quarter ended December 2022. There were no Sales reported in the quarter ended December 2023 and during the previous quarter ended December 2022.
Powered by Capital Market - Live News
Welcure Drugs & Pharmaceuticals to discuss results
78 days ago

Welcure Drugs & Pharmaceuticals to discuss results

01 - Feb - 2024 12:00 AM | 78 days ago

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 February 2024.
Powered by Capital Market - Live News
Welcure Drugs & Pharmaceuticals reports standalone net loss of Rs 0.10 crore in the September 2023 quarter
156 days ago

Welcure Drugs & Pharmaceuticals reports standalone net loss of Rs 0.10 crore in the September 2023 quarter

15 - Nov - 2023 12:00 AM | 156 days ago

Net Loss of Welcure Drugs & Pharmaceuticals reported to Rs 0.10 crore in the quarter ended September 2023 as against net loss of Rs 0.01 crore during the previous quarter ended September 2022. There were no Sales reported in the quarter ended September 2023 and during the previous quarter ended September 2022.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Welcure Drugs & Pharmaceuticals Ltd has the Lowesr P/E ratio according to FY 202303 data among stocks in Pharmaceuticals Sector
Welcure Drugs & Pharmaceuticals Ltd has the Lowesr P/B ratio according to FY 202303 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Welcure Drugs & Pharmaceuticals Ltd Share Price – BSE Pharmaceuticals, Small Cap

4.40 -0.02 (-0.45%)

News & Announcements

Price vs Volume

Stock Trivia

Welcure Drugs & Pharmaceuticals Ltd Share Price – BSE
Pharmaceuticals, Small Cap

4.40

-0.02 (-0.45%)